Genscript Biotech Corp
SWB:G51
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genscript Biotech Corp
SWB:G51
|
CN |
|
O
|
Odd Burger Corp
XTSX:ODD
|
CA |
|
Valid Solucoes SA
OTC:VSSPY
|
BR |
|
Valid Solucoes SA
BOVESPA:VLID3
|
BR |
|
T
|
Trican Well Service Ltd
OTC:TOLWF
|
CA |
|
B
|
Burberry Group PLC
XMUN:BB2
|
UK |
|
Nakanishi Inc
F:6SN
|
JP |
Wall St Price Targets
G51 Price Targets Summary
Genscript Biotech Corp
According to Wall Street analysts, the average 1-year price target for G51 is 2.13 EUR with a low forecast of 1.68 EUR and a high forecast of 3.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G51's stock price target?
Price Target
2.13
EUR
According to Wall Street analysts, the average 1-year price target for G51 is 2.13 EUR with a low forecast of 1.68 EUR and a high forecast of 3.25 EUR.
What is the Revenue forecast for Genscript Biotech Corp?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 7 years is 7%.
What is the Gross Profit forecast for Genscript Biotech Corp?
Projected CAGR
-2%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is -2%.
What is the Operating Income forecast for Genscript Biotech Corp?
Projected CAGR
-3%
Over the last 12 years, the compound annual growth rate for Operating Income has been 34%. The projected CAGR for the next 7 years is -3%.
